India to Philippines: Paclitaxel Export Trade Route
India has recorded 190 verified shipments of Paclitaxel exported to Philippines, representing a combined trade value of $2.5M USD. This corridor is served by 27 active Indian exporters, with an average shipment value of $13.0K USD. The leading Indian exporter is PRIME PHARMACEUTICALS PRIVATE LIMITED, which accounts for 17% of total export value with 12 shipments worth $424.9K USD. On the buying side, TO THE ORDER OF is the largest importer in Philippines with $341.8K USD in purchases. The top 3 suppliers — PRIME PHARMACEUTICALS PRIVATE LIMITED, CELON LABORATORIES PRIVATE LIMITED, VEXXA LIFESCIENCES PVT. LTD. — together control 38% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Paclitaxel corridor is one of India's established pharmaceutical export routes, with 190 shipments documented worth a combined $2.5M USD. The route is dominated by PRIME PHARMACEUTICALS PRIVATE LIMITED, which alone accounts for roughly 17% of all export value, reflecting the consolidated nature of India's paclitaxel manufacturing sector.
Across 27 active suppliers, the average shipment value stands at $13.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with paclitaxel's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 33.5%, placing it at rank #5 among India's top paclitaxel export destinations globally.
On the import side, key buyers of Indian paclitaxel in Philippines include TO THE ORDER OF, VE PHARMA INC, AMBICA INTERNATIONAL CORPORATION and 48 others. TO THE ORDER OF is the single largest importer with 9 shipments valued at $341.8K USD.
Route Characteristics
- Average transit26 days
- Peak seasonQ4
- Primary modeSea freight
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#5
- Annual growth+33.5%
- Demand growth+27.9%
- Regulatory ease85/100
Top 10 Indian Paclitaxel Exporters to Philippines
Showing top 10 of 27 Indian suppliers exporting Paclitaxel to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PRIME PHARMACEUTICALS PRIVATE LIMITED Avg $35.4K per shipment | 12 | $424.9K | 17.2% |
| 2 | CELON LABORATORIES PRIVATE LIMITED Avg $35.1K per shipment | 8 | $281.1K | 11.4% |
| 3 | VEXXA LIFESCIENCES PVT. LTD. Avg $6.9K per shipment | 33 | $227.8K | 9.2% |
| 4 | ADMAC LIFESCIENCES Avg $12.1K per shipment | 16 | $193.3K | 7.8% |
| 5 | STALLION LABORATORIES PVT LTD Avg $19.2K per shipment | 10 | $192.4K | 7.8% |
| 6 | GETWELL PHARMA INDIA PRIVATE LIMITED Avg $40.3K per shipment | 4 | $161.2K | 6.5% |
| 7 | NAPROD LIFE SCIENCES PRIVATE LIMITED Avg $27.7K per shipment | 4 | $110.8K | 4.5% |
| 8 | FRESENIUS KABI ONCOLOGY LIMITED Avg $9.0K per shipment | 12 | $107.5K | 4.4% |
| 9 | VEXXA LIFESCIENCES PVT. LTD. Avg $6.0K per shipment | 17 | $102.0K | 4.1% |
| 10 | KHANDELWAL LABORATORIES PRIVATE LIMITED Avg $23.5K per shipment | 4 | $93.8K | 3.8% |
This table shows the top 10 of 27 Indian companies exporting paclitaxel to Philippines, ranked by total trade value. The listed exporters are: PRIME PHARMACEUTICALS PRIVATE LIMITED, CELON LABORATORIES PRIVATE LIMITED, VEXXA LIFESCIENCES PVT. LTD., ADMAC LIFESCIENCES, STALLION LABORATORIES PVT LTD, GETWELL PHARMA INDIA PRIVATE LIMITED, NAPROD LIFE SCIENCES PRIVATE LIMITED , FRESENIUS KABI ONCOLOGY LIMITED, VEXXA LIFESCIENCES PVT. LTD. , KHANDELWAL LABORATORIES PRIVATE LIMITED. PRIME PHARMACEUTICALS PRIVATE LIMITED is the dominant supplier with 12 shipments worth $424.9K USD, giving it a 17% market share. The top 3 suppliers together account for 38% of the total trade value on this route.
Showing top 10 of 27 total Indian exporters on the India to Philippines Paclitaxel export route.
Top 10 Paclitaxel Importers in Philippines
Showing top 10 of 51 known buyers in Philippines receiving Paclitaxel shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian paclitaxel in Philippines include TO THE ORDER OF, VE PHARMA INC, AMBICA INTERNATIONAL CORPORATION, I.E MEDICA INC, I E MEDICA INC, among 51 total buyers. The largest importer is TO THE ORDER OF, accounting for $341.8K USD across 9 shipments — representing 14% of all paclitaxel imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TO THE ORDER OF | 9 | $341.8K | 13.9% |
| 2 | VE PHARMA INC | 47 | $314.4K | 12.8% |
| 3 | AMBICA INTERNATIONAL CORPORATION | 5 | $174.4K | 7.1% |
| 4 | I.E MEDICA INC | 2 | $133.3K | 5.4% |
| 5 | I E MEDICA INC | 1 | $113.8K | 4.6% |
| 6 | ASIA UNITED BANK | 1 | $97.3K | 3.9% |
| 7 | Multicare Pharmaceuticals Philippin | 3 | $96.7K | 3.9% |
| 8 | TO THE ORDER OF. | 5 | $91.5K | 3.7% |
| 9 | Ve Pharma Inc. | 16 | $89.8K | 3.6% |
| 10 | ORANGE BIOTEC INCORPORATED | 5 | $85.1K | 3.5% |
Showing top 10 of 51 Paclitaxel importers in Philippines on this route.
Top 10 Paclitaxel Formulations Imported by Philippines
Showing top 10 of 137 product formulations shipped on the India to Philippines Paclitaxel route, ranked by trade value
Philippines imports a wide range of paclitaxel formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CELTAX PACLITAXEL INJECTION 150MG (ALONGWITH 21.000NOS FREE SAMPLES) — accounts for $125.6K USD across 1 shipments. There are 137 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CELTAX PACLITAXEL INJECTION 150MG (ALONGWITH 21.000NOS FREE SAMPLES) | 1 | $125.6K | 5.1% |
| 2 | CELTAX 150PACLITAXEL INJ.150MG ALONG WITH 6 NOS OF FREE SAMPLES | 1 | $113.8K | 4.6% |
| 3 | PHARMACEUTICALS PRODUCT MACROTAXEL 260MG(PACLITAXEL INJECTION USP (260MG/43.4ML) BATCH: X5BPA016A M:02/2025 E:01/2027 | 1 | $113.1K | 4.6% |
| 4 | MACROTAXEL 260MG PACLITAXEL INJECTION USP 260MG/43.4ML B/NO X3HP036B MF 08/23 EX 07/25B/NO X3IPA066A X3IPA076A | 1 | $97.3K | 3.9% |
| 5 | PACLINANO 100MG (PACLITAXEL (PROTEIN-BOUND PARTICLES) FOR INJ. SUSPENSION) BATCH NO. 5GPNL03, MFG.DT. 02/2025, EXP 01/27 | 1 | $71.9K | 2.9% |
| 6 | PACLINANO 100MG PACLITAXEL PROTEIN BOUND PARTICLES FOR INJECTABLE SUSPENSION B 5GPNL08 M 05 2025 E 04 2027 | 1 | $71.4K | 2.9% |
| 7 | MACROTAXEL 1X20ML (PACLITAXEL INJECTIONUSP 100MG/16.67ML) BATCH: X5CPA082A MFG: 03/2025 EXP: 02/2027 | 2 | $71.2K | 2.9% |
| 8 | Vexel 100 Inj (PACLITAXEL INJECTION 100MG) BATCH NO-PCIB25AB02-A MFG DT-FEB-2025 EXP DT-JAN-2027 | 4 | $71.0K | 2.9% |
| 9 | Napro-Tax 260mg/43.34ml Paclitaxel Injec | 2 | $64.0K | 2.6% |
| 10 | CANSURE (PACLITAXEL SOLUTION FOR INJECTI | 4 | $56.4K | 2.3% |
Showing top 10 of 137 Paclitaxel formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 81%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 57 shipments. Transit time averages 26 days by sea.
Market Dynamics
India's paclitaxel exports to Philippines are driven primarily by a handful of large-scale manufacturers. PRIME PHARMACEUTICALS PRIVATE LIMITED with 12 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 27 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — PRIME PHARMACEUTICALS PRIVATE LIMITED, CELON LABORATORIES PRIVATE LIMITED, VEXXA LIFESCIENCES PVT. LTD. — together account for 38% of total trade value on this route. The average shipment value of $13.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as celtax 150paclitaxel inj.150mg along with 6 nos of free samples and pharmaceuticals product macrotaxel 260mg(paclitaxel injection usp (260mg/43.4ml) batch: x5bpa016a m:02/2025 e:01/2027, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TO THE ORDER OF is the largest importer with 9 shipments worth $341.8K USD — representing 14% of all paclitaxel imports from India on this route. A total of 51 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.5M
- Avg. Shipment
- $13.0K
- Suppliers
- 27
- Buyers
- 51
- Transit (Sea)
- ~26 days
- Annual Growth
- +33.5%
Related Analysis
Other Paclitaxel Routes
Unlock the Full India to Philippines Paclitaxel Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 190 shipments on this route.
Frequently Asked Questions — India to Philippines Paclitaxel Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Paclitaxel to Philippines?
The leading Indian exporters of Paclitaxel to Philippines are PRIME PHARMACEUTICALS PRIVATE LIMITED, CELON LABORATORIES PRIVATE LIMITED, VEXXA LIFESCIENCES PVT. LTD.. PRIME PHARMACEUTICALS PRIVATE LIMITED holds the largest market share at approximately 17% of total trade value on this route.
Q What is the total value of Paclitaxel exports from India to Philippines?
India exports Paclitaxel to Philippines worth approximately $2.5M USD across 190 recorded shipments. The average value per shipment is $13.0K USD.
Q Which ports does India use to ship Paclitaxel to Philippines?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 57 shipments. Indian exporters primarily use sea freight for this route, with 81% of shipments going by sea and 27% by air.
Q How long does shipping take from India to Philippines for Paclitaxel?
The average transit time for Paclitaxel shipments from India to Philippines is approximately 26 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Philippines Paclitaxel trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 33.5% with demand growth tracking at 27.9%. The route is ranked #5 among India's top Paclitaxel export destinations globally.
Q How many suppliers are active on the India to Philippines Paclitaxel route?
There are currently 27 active Indian suppliers exporting Paclitaxel to Philippines. The market is moderately concentrated with PRIME PHARMACEUTICALS PRIVATE LIMITED accounting for 17% of total shipment value.
Q Who are the main importers of Paclitaxel from India in Philippines?
The leading importers of Indian Paclitaxel in Philippines include TO THE ORDER OF, VE PHARMA INC, AMBICA INTERNATIONAL CORPORATION, I.E MEDICA INC, I E MEDICA INC. TO THE ORDER OF is the largest buyer with 9 shipments worth $341.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Paclitaxel.
- 2.Supplier/Buyer Matching: 27 Indian exporters and 51 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 190 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
190 Verified Shipments
27 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists